Multiple Sclerosis Treatment – CFN Media

Healthcare Stocks

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

Nets CAD$15,480,780 cash in non-dilutive capital Current cash position of approximately CAD$50…

Ryan Allway
May 10, 2022

Healthcare Stocks

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board

Mr. Allan, the 2017 winner of the prestigious Julia Levy Award, to…

Ryan Allway
April 21, 2022

FSD Pharma’s Team Advancing a New Approach to Multiple Sclerosis

Multiple sclerosis, or MS, is a degenerative neurological disorder that makes life…

Robin Lefferts
April 20, 2022

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Cardiol’s Favorable Phase 2 Results Set the Table for Advanced Clinical Trials

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) recently presented excellent…

Robin Lefferts
November 20, 2024

Aduro Clean Technologies Engages Global Leader Zeton for Design and Fabrication of Hydrochemolytic™ Pilot Plant

Milestone Project to Demonstrate Aduro’s Modular, Scalable Solution for Converting…

Ryan Allway
November 19, 2024

IKE Tech LLC and Ispire Technology Inc. Announce Positive Pre-PMTA Submission Meeting with the FDA

Seeks Authorization for Pioneering Point-of-Use Identity and Age Verification…

Ryan Allway
November 18, 2024

Healthcare Stocks

Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Marked and rapid reductions in both pericarditis pain and inflammation maintained…

Ryan Allway
November 18, 2024